Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

OBJECTIVE: To expand on available information on the efficacy of oral lasmiditan for the acute treatment of migraine with particular focus on the timing of the effect and on its impact on migraine‐associated symptoms. BACKGROUND: Lasmiditan is a novel selective 5‐hydroxytryptamine 1F receptor agonis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Headache
Hauptverfasser: Ashina, Messoud, Vasudeva, Raghavendra, Jin, Leah, Lombard, Louise, Gray, Elizabeth, Doty, Erin G., Yunes‐Medina, Laura, Kinchen, Kraig S., Tassorelli, Cristina
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Research Submissions
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899640/
https://ncbi.nlm.nih.gov/pubmed/31529622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13636
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge